My commentary in @ConversationCA highlights lessons from climate change for the UNGA High-level Meeting on AMR:
1️⃣ Adopt unifying goals to rally public and political support
2️⃣ Create a scientific panel to provide policymakers with the evidence they need
https://t.co/g2esjr37ov
Drawing on interviews with 12 #AMR policy experts across five WOAH regions, our new study proposes a framework for livestock antimicrobial use policy built on 3 pathways: animal health systems, supply chain regulation, and stewardship: https://t.co/oMEytU522y
#UndertheMicroscope
📌 Nov 23: GSL Director @MathieuJPP joins the discussion panel for “TrACSS at 10 Years,” a Quadripartite webinar marking a decade of tracking how countries implement their national action plans on #AMR.
🕖 7:00–8:30 a.m. ET / 13:00–14:30 CET
Register: https://t.co/23e16CdOBh
There’s no single model for #OneHealth governance of #AMR. What works depends on national contexts. Join @WHO and GSL on 19 Nov for "Context-Specific One Health Governance for Antimicrobial Resistance: Conceptual Framework and Country Experiences." ➡️ https://t.co/m1aauxMa8n
📢 Looking for your next academic chapter?
GSL is recruiting an international PhD student to research accountability in global #AMR governance.
Applying takes 3 steps. First deadline: Nov 23.
Details: https://t.co/gnrIN4KsRH
In a new @UNUCPR policy memo, GSL Director @MathieuJPP argues that amid disinformation, institutional defunding & eroding trust in science, science-policy interface models are under threat. ➡️ #IPEA is a chance to prove multisectoral collaboration works 📌https://t.co/cJMeGk9DR8
🌏 The same One Health governance approach can produce very different results in different places.
Why❓
Our new scoping review of 171 studies across 50+ countries finds context, not the model, often decides success.
🔗 Read in @bmj_latest BMJ Open: https://t.co/govVWJUeKw
New GSL research advances the emerging field of global legal epidemiology (GLE). Using case studies, it examines the practical challenges of applying legal epidemiology at a global scale & offers practical approaches to address them ➡️ https://t.co/VWYJP1K7yQ
#LegalEpidemiology
Strengthening Global Action on AMR with Context-Specific Governance. A new article written by GSL's Arne Ruckert, Geneviève Boily-Larouche and @MathieuJPP ⬇️ https://t.co/Dg9WRMOe9q
We can't improve what we don’t evaluate.
Two-thirds of all antimicrobials are used in production animals, yet almost none of the policies meant to reduce that use are ever evaluated. Our new One Health commentary lays out a smarter path forward. ➡️ https://t.co/wj73Z239zB
#AMR
A new GSL led @WHO Bulletin systematic review finds that when bans, restrictions & stewardship policies are in place, antimicrobial use drops 20–80%. This study revealed not only what works, but also where evidence gaps exist.
Read here: https://t.co/RCY3vzGtOI
#AMR
The 2025 AMR Policy Accelerator Impact Report is out!
Look back on our year dedicated to:
🔸advancing AMR global governance
🔸actioning evidence-informed national policymaking, and
🔸strengthening AMR policymaking capacity
➡️ https://t.co/Co7nUEm7vH
@YorkUniversity
🔎Just published in @GlobalHealthBMJ! Our new paper (in collaboration with @KSAU_Ottawa ) explores how COVID-19 shaped antimicrobial resistance (AMR). Read here🔗 https://t.co/JDccJplyHE
#AMR#OpenAccess
The Independent Panel on Evidence for Action Against AMR (IPEA) is foundational for global action against AMR.
Our policy brief with @ESCMID highlights how IPEA can deliver policy-relevant evidence.
Some key take-aways:
How can IPEA, launching this December, maximize its outputs to be timely, credible & equitable?
This policy brief with @ESCMID explores how IPEA can organize its scientific work to ensure relevant, policy-responsive evidence on #AMR.
📚https://t.co/KvieiH8Wp5
⏰Nov 20: Don’t miss this #WAAW2025 webinar bringing together artists & storytellers to share how their work, including comics, games & immersive storytelling, is building public awareness & inspiring action on #AMR.
Learn more & register: https://t.co/dYCzgV5iCu
Applications are due in two weeks!
This position will further strengthen @YorkUHealth's capacity around implementation science, with @kerfully's appointment last year as an Assistant Professor in Implementation Science and Knowledge Mobilization.
How do gender dynamics impact health outcomes related to antimicrobial resistance (#AMR)? 💊🌎
For a quick overview of our study, explore the summary: https://t.co/UIHeOU4F2Y
#GenderAndAMR
The IPSA (@ipsa_aisp) World Congress kicks off in Seoul! GSL’s Gabriel Fezza & @MathieuJPP will present research on how institutional, economic & political factors shape the effectiveness of international laws.
📌Join their panel July 15, 3:30 PM KST @ Coex [3F 308B]. #IPSA2025
New research coming out of Global Strategy Lab ahead of World No Tobacco Day finds a lack of a gender lens in most tobacco control research, despite men and women having different smoking behaviours. https://t.co/BwcbYGkFhf @gstrategylab@MathieuJPP@YorkUHealth
#AntimicrobialResistance kills millions, and no country can tackle it alone. In #BellagioBreakthroughs, I discuss how the 1-10-100 goals can help forge global consensus and create equitable, win-win solutions. https://t.co/GKweOJYOob